Atlas Trials

Phase II Cohort A: Relapsed or Refractory Mantle Cell Lymphoma

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Phase II Cohort A: Relapsed or Refractory Mantle Cell Lymphoma

RecordFirmDate
Study of Acalabrutinib in Chinese Adult Subjects With Relapsed or Refractory Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia or Other B-cell Malignancies (NCT03932331)AstraZeneca2020-04-29

Track Phase II Cohort A: Relapsed or Refractory Mantle Cell Lymphoma automatically

Every clearance here is in the API, with alerts when new ones post.